Skip to content

UPALProShares Ultra Palladium K-1 Free ETF

Beat inflationNewRanked #110 of 114 in this goal

Seeks daily investment results that correspond to 2x the daily performance of the price of palladium.

By ProShares · Launched 2026

Annual Cost

0.95%

#4,684 of 5,562 · expensive

Fund Size

$3M

#5,214 of 5,562 · small

Return (1Y)Goal

N/A

Track Record

2 months

#5,396 of 5,562 · young

Performance

Total-return NAV · USD
Growth of $10,000
$6,763-32.4%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Commodity

Strategy

Leveraged

Index tracked

LBMA Palladium Price

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
N/A
Max drawdown
-42.9%Severe

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks daily investment results that correspond to 2x the daily performance of the price of palladium.
Strategy
Invests in financial instruments to achieve daily returns that correspond to 2x the price of palladium. Does not invest directly in palladium, using derivatives for exposure.
Inception date
April 20, 2026
Fund family
ProShares

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Leveraged
Warning

Leveraged ETF — not a long-term hold

This fund uses leverage to amplify daily returns (e.g. 2x or 3x of an index). Daily rebalancing creates volatility decay — over weeks and months, the fund's return drifts from the stated multiple. In trending markets with low realised volatility, leveraged index ETFs can outperform their nominal multiple; in sideways or volatile markets they bleed. Designed for short-term tactical use, not buy-and-hold.

Source: Cheng & Madhavan, 'The Dynamics of Leveraged and Inverse ETFs' (2009)

Why we flagged this: strategy=leveraged + leveraged_name_or_strategy

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've reviewed UPAL. Save it to your watchlist to track it alongside the other funds you're weighing.

Data updated on 2026-06-19